The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

The company, which pioneered CGM technology 25 years ago, has secured access to its Dexcom ONE sensor for around 100,000 T2D users in France. The reimbursement guidance offers people aged over two ...

Oura and Dexcom inked a deal to have the Oura Ring app show blood sugar readings from a Dexcom sensor like the Stelo.

In 2025 the Oura Ring will integrate with Dexcom glucose sensors Dexcom data will sit alongside other health points within the Oura app Dexcom is investing $75 million into Oura, now valued at ...

DexCom DXCM, a leader in glucose biosensing systems, has announced a strategic partnership with OURA, the developer of a ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

A Barron’s feature in June presented the outlook for smartwatches and patch sensors from Apple, Abbott Laboratories, DexCom, Alphabet’s Google, iRhythm Technologies and others. Medical-device ...

Glucose Sensor Market. The global glucose sensor market is projected to witness substantial growth, reaching a valuation of ...